Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials.

Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials.

Published version

Peer-reviewed

Repository URI

https://www.repository.cam.ac.uk/handle/1810/327924

Repository DOI

https://doi.org/10.17863/CAM.75377

Files

Published version (108.67 KB)

Type

Authors

Goodman, Anna L

Gupta, Ravindra K

Jolles, Stephen

Keywords

Antiviral Agents, Health Services Accessibility, Humans, COVID-19 Drug Treatment

Journal Title

Lancet Infect Dis

Journal ISSN

1473-3099
1474-4457

Volume Title

21

Publisher

Elsevier

Publisher DOI

https://doi.org/10.1016/S1473-3099(21)00464-3

Rights and licensing

Publisher's own licence

Except where otherwised noted, this item's license is described as Publisher's own licence

Collections

University of Cambridge Research Outputs (Articles and Conferences)